Quarterly report pursuant to Section 13 or 15(d)

Non-controlling Interest

v3.7.0.1
Non-controlling Interest
6 Months Ended
Jun. 30, 2017
Noncontrolling Interest [Abstract]  
Noncontrolling Interest Disclosure [Text Block]
8. Non-controlling Interest
 
The Company’s non-controlling interest is accounted for under ASC 810, Consolidation and represents the minority shareholder’s ownership interest related to the Company’s subsidiary, Synthetic Biomics, Inc. (“SYN Biomics”). In accordance with ASC 810, the Company reports its non-controlling interest in subsidiaries as a separate component of equity in the condensed consolidated balance sheets and reports both net loss attributable to the non-controlling interest and net loss attributable to the Company and its subsidiaries on the face of the condensed consolidated statements of operations. The Company’s equity interest in SYN Biomics is 88.5% and the non-controlling stockholder’s interest is 11.5%. For the three and six months ended June 30, 2017, the accumulated net loss attributable to the non-controlling interest was $60,000 and $272,000, respectively.